Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bioaffinity.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adarx, Agenus, Altrubio, Ideaya, Illuminare, Ipsen, Mallinckrodt, Mannkind, Oncxerna, Pliant, Priothera, Regenxbio, Rhythm, TME, Ultimovacs.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Reddress, Samsara Vision.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Altrubio, Astellas, Epicentrx, Hangzhou HiglightII, Hepagene, Immunitybio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Neurosense, Surmodics, Universal DX.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Apex, Apexigen, Bellerophon, Biocorrx, Canbridge, Janssen, Jazz, Palatin, Roche, Sonnet, Sotio, Stemedica, Xortx, Zymeworks.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Algernon, Asher, Beigene, Cardiol, Ceruvia, Dong-A, Edesa, Everest, Horizon, Irlab, Junshi, Keymed, Moderna, Monopar, Oryzon, Plus, Servier, Trefoil.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Vasc-Alert.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abionyx, Arcutis, Ascletis, Avacta, Avalo, Biomea Fusion, Cardiol, Clinuvel, Everimmune, GPCR, IGM, Kancera, Newamsterdam, Reneo, Theriva.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adagene, Arrowhead, Hightide, Jacobio, Sorrento, Takeda.